ARTICLE | Clinical News
Triferic soluble ferric pyrophosphate citrate regulatory update
November 10, 2014 8:00 AM UTC
Rockwell said FDA's Oncologic Drugs Advisory Committee voted 8-3 that data for the company's Triferic soluble ferric pyrophosphate citrate support a positive benefit/risk to treat iron loss to maintai...